CONCENTRATIONS	9 Months Ended
Sep. 30, 2021
Risks and Uncertainties [Abstract]
CONCENTRATIONS	NOTE L – CONCENTRATIONS Revenue from the Company’s Remote Power Patent constituted 100% of the Company’s revenue for the three and nine months ended September 30, 2021. Revenue from one licensee constituted 100% of the Company’s revenue for the three months ended September 30, 2021 and revenue from two licensees constituted 100% of the Company’s revenue for the nine months ended September 30, 2021. Revenue from one licensee constituted 100% of the Company’s revenue for the three months ended September 30, 2020 and 95% of the Company’s revenue for the nine months ended September 30, 2020. At September 30, 2021 and December 31, 2020, the Company had no royalty receivables.

The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date.

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 275
-URI http://asc.fasb.org/topic&trid=2134479

Name:	us-gaap_ConcentrationRiskDisclosureTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration